98 related articles for article (PubMed ID: 30876538)
21. Cerium dioxide-doped carboxyl fullerene as novel nanoprobe and catalyst in electrochemical biosensor for amperometric detection of the CYP2C19*2 allele in human serum.
Zhang C; He J; Zhang Y; Chen J; Zhao Y; Niu Y; Yu C
Biosens Bioelectron; 2018 Apr; 102():94-100. PubMed ID: 29127901
[TBL] [Abstract][Full Text] [Related]
22. DNA electrochemical sensor for detection of PRSS1 point mutation based on restriction endonuclease technique.
Qicai L; Qiang Y; Wennan W; Yu W; Liqing L; Chengfei Z; Xinhua L
Prep Biochem Biotechnol; 2015; 45(5):430-7. PubMed ID: 25037001
[TBL] [Abstract][Full Text] [Related]
23. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
[TBL] [Abstract][Full Text] [Related]
24. Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products.
Kristensen LS; Daugaard IL; Christensen M; Hamilton-Dutoit S; Hager H; Hansen LL
Hum Mutat; 2010 Dec; 31(12):1366-73. PubMed ID: 20848649
[TBL] [Abstract][Full Text] [Related]
25. A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples.
Wu S; Zhu Z; He J; Luo X; Xu J; Ren-Heidenreich L
Clin Chem Lab Med; 2010 Aug; 48(8):1103-6. PubMed ID: 20482381
[TBL] [Abstract][Full Text] [Related]
26. Surface Enhanced Raman Spectroscopy (SERS) for the Multiplex Detection of Braf, Kras, and Pik3ca Mutations in Plasma of Colorectal Cancer Patients.
Li X; Yang T; Li CS; Song Y; Lou H; Guan D; Jin L
Theranostics; 2018; 8(6):1678-1689. PubMed ID: 29556349
[TBL] [Abstract][Full Text] [Related]
27. KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations.
Oka M; Kushamae M; Aoki T; Yamaguchi T; Kitazato K; Abekura Y; Kawamata T; Mizutani T; Miyamoto S; Takagi Y
World Neurosurg; 2019 Jun; 126():e1365-e1373. PubMed ID: 30902772
[TBL] [Abstract][Full Text] [Related]
28. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing.
Mack E; Stabla K; Riera-Knorrenschild J; Moll R; Neubauer A; Brendel C
BMC Cancer; 2016 Aug; 16():585. PubMed ID: 27485514
[TBL] [Abstract][Full Text] [Related]
29. Double-hairpin molecular-beacon-based amplification detection for gene diagnosis linked to cancer.
Xu H; Zhang R; Li F; Zhou Y; Peng T; Wang X; Shen Z
Anal Bioanal Chem; 2016 Sep; 408(22):6181-8. PubMed ID: 27422649
[TBL] [Abstract][Full Text] [Related]
30. Detection of Janus Kinase 2 gene single point mutation in real samples with electrochemical DNA biosensor.
Topkaya SN; Kosova B; Ozsoz M
Clin Chim Acta; 2014 Feb; 429():134-9. PubMed ID: 24333614
[TBL] [Abstract][Full Text] [Related]
31. EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients.
Créquit P; Ruppert AM; Rozensztajn N; Gounant V; Vieira T; Poulot V; Antoine M; Chouaid C; Wislez M; Cadranel J; Lavole A
Lung Cancer; 2016 Jun; 96():74-7. PubMed ID: 27133754
[TBL] [Abstract][Full Text] [Related]
32. [KRAS mutation assay on EUS-FNA specimens from pacients with pancreatic mass].
Bunganič B; Hálková T; Benešová L; Belšánová B; Laclav M; Hrůzová M; Traboulsi E; Frič P; Suchánek Š; Minárik M; Zavoral M
Cas Lek Cesk; 2016; 155(1):48-51. PubMed ID: 26898792
[TBL] [Abstract][Full Text] [Related]
33. Electrochemical biosensors for detection of point mutation based on surface ligation reaction and oligonucleotides modified gold nanoparticles.
Wang Q; Yang L; Yang X; Wang K; He L; Zhu J
Anal Chim Acta; 2011 Mar; 688(2):163-7. PubMed ID: 21334481
[TBL] [Abstract][Full Text] [Related]
34. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
[TBL] [Abstract][Full Text] [Related]
35. A chronocoulometric LNA sensor for amplified detection of K-ras mutation based on site-specific DNA cleavage of restriction endonuclease.
Lin L; Liu A; Zhao C; Weng S; Lei Y; Liu Q; Lin X; Chen Y
Biosens Bioelectron; 2013 Apr; 42():409-14. PubMed ID: 23220265
[TBL] [Abstract][Full Text] [Related]
36. Single-Molecule Counting of Point Mutations by Transient DNA Binding.
Su X; Li L; Wang S; Hao D; Wang L; Yu C
Sci Rep; 2017 Mar; 7():43824. PubMed ID: 28262827
[TBL] [Abstract][Full Text] [Related]
37. Constitutively active Akt1 cooperates with KRas(G12D) to accelerate in vivo pancreatic tumor onset and progression.
Albury TM; Pandey V; Gitto SB; Dominguez L; Spinel LP; Talarchek J; Klein-Szanto AJ; Testa JR; Altomare DA
Neoplasia; 2015 Feb; 17(2):175-82. PubMed ID: 25748236
[TBL] [Abstract][Full Text] [Related]
38. A novel ligase chain reaction-based electrochemical biosensing strategy for highly sensitive point mutation detection from human whole blood.
Liu ZJ; Yang LY; Wei QX; Ye CL; Xu XW; Zhong GX; Zheng YJ; Chen JY; Lin XH; Liu AL
Talanta; 2020 Aug; 216():120966. PubMed ID: 32456905
[TBL] [Abstract][Full Text] [Related]
39. Co-dependency of PKCδ and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer.
Ohm AM; Tan AC; Heasley LE; Reyland ME
Oncogene; 2017 Jul; 36(30):4370-4378. PubMed ID: 28368426
[TBL] [Abstract][Full Text] [Related]
40. Survival in ampullary cancer: potential role of different KRAS mutations.
Valsangkar NP; Ingkakul T; Correa-Gallego C; Mino-Kenudson M; Masia R; Lillemoe KD; Fernández-del Castillo C; Warshaw AL; Liss AS; Thayer SP
Surgery; 2015 Feb; 157(2):260-8. PubMed ID: 25616942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
